CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens

Immunology and Cell Biology

Volumn 90, Issue 7, 2012, Pages 699-709

  Hayworth, Jacqueline L ^a   Mazzuca, Delfina M ^a   Maleki Vareki, Saman ^a   Welch, Ian ^b   McCormick, John K ^a,b,c   Haeryfar, Sm Mansour ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD69 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAPHYLOCOCCUS ENTEROTOXIN B; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYBRIDOMA; INVARIANT NATURAL KILLER T CELL; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD1D; CELL LINE; CELLS, CULTURED; ENTEROTOXINS; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; HLA-DR4 ANTIGEN; HUMANS; HYBRIDOMAS; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 84864847925     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.90     Document Type: Article

References (64)

1. Sundberg EJ, Deng L, Mariuzza RA. TCR recognition of peptide/MHC class II complexes and superantigens. Semin Immunol 2007; 19: 262-271. (Pubitemid 47043487)
2. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 1066.
3. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 2001; 55: 77-104. (Pubitemid 32978101)
4. Herrmann T, Baschieri S, Lees RK, MacDonald HR. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens. Eur J Immunol 1992; 22: 1935-1938.
5. Fuller CL, Braciale VL. Selective induction of CD8+ cytotoxic T lymphocyte effector function by staphylococcus enterotoxin B. J Immunol 1998; 161: 5179-5186. (Pubitemid 28519075)
6. Maeurer M, Zitvogel L, Elder E, Storkus WJ, Lotze MT. Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA. Nat Immun 1995; 14: 188-197. (Pubitemid 26146446)
7. Morita CT, Li H, Lamphear JG, Rich RR, Fraser JD, Mariuzza RA et al. Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors. Immunity 2001; 14: 331-344. (Pubitemid 32289296)
8. Taylor AL, Llewelyn MJ. Superantigen-induced proliferation of human CD4+CD25-T cells is followed by a switch to a functional regulatory phenotype. J Immunol 2011; 185: 6591-6598.
9. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877-900. (Pubitemid 40563188)
10. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336. (Pubitemid 46697911)
11. Van Kaer L, Parekh VV, Wu L. Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens. Immunotherapy 2011; 3: 59-75.
12. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, Koh R et al. CD1d-lipidantigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007; 448: 44-49. (Pubitemid 47037002)
13. Fowlkes BJ, Kruisbeek AM, Ton-That H, Weston MA, Coligan JE, Schwartz RH et al. A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature 1987; 329: 251-254. (Pubitemid 17128969)
14. Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J Exp Med 1994; 180: 1097-1106. (Pubitemid 24256622)
15. Mallevaey T, Scott-Browne JP, Matsuda JL, Young MH, Pellicci DG, Patel O et al. T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire. Immunity 2009; 31: 60-71.
16. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003; 198: 1069-1076. (Pubitemid 37248622)
17. Venkataswamy MM, Porcelli SA. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 2011; 22: 68-78.
18. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007; 5: 405-417. (Pubitemid 46780078)
19. Kim S, Lalani S, Parekh VV, Vincent TL, Wu L, Van Kaer L. Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice. J Clin Invest 2008; 118: 2301-2315. (Pubitemid 351872347)
20. Brigl M, Brenner MB. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin Immunol 2010; 22: 79-86.
21. Pei B, Speak AO, Shepherd D, Butters T, Cerundolo V, Platt FM et al. Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids. J Immunol 2011; 186: 1348-1360.
22. Brouillard JN, Gunther S, Varma AK, Gryski I, Herfst CA, Rahman AK et al. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. J Mol Biol 2007; 367: 925-934. (Pubitemid 46386067)
23. Malchiodi EL, Eisenstein E, Fields BA, Ohlendorf DH, Schlievert PM, Karjalainen K et al. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med 1995; 182: 1833-1845.
24. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158: 2723-2730. (Pubitemid 127470530)
25. Mollick JA, Chintagumpala M, Cook RG, Rich RR. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol 1991; 146: 463-468.
26. De Marzi MC, Fernandez MM, Sundberg EJ, Molinero L, Zwirner NW, Llera AS et al. Cloning, expression and interaction of human T-cell receptors with the bacterial superantigen SSA. Eur J Biochem 2004; 271: 4075-4083. (Pubitemid 39423105)
27. Sundberg EJ, Li H, Llera AS, McCormick JK, Tormo J, Schlievert PM et al. Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure 2002; 10: 687-699. (Pubitemid 34520468)
28. Mannik LA, Chin-Yee I, Sharif S, Van Kaer L, Delovitch TL, Haeryfar SM. Engagement of glycosylphosphatidylinositol-anchored proteins results in enhanced mouse and human invariant natural killer T cell responses. Immunology 2011; 132: 361-375.
29. Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 2005; 202: 1279-1288. (Pubitemid 41586958)
30. Hong C, Park SH. Application of natural killer T cells in antitumor immunotherapy. Crit Rev Immunol 2007; 27: 511-525.
31. Berzins SP, Smyth MJ, Godfrey DI. Working with NKT cells-pitfalls and practicalities. Curr Opin Immunol 2005; 17: 448-454.
32. Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED et al. Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 2009; 15: 641-648.
33. Hayworth JL, Kasper KJ, Leon-Ponte M, Herfst CA, Yue D, Brintnell WC et al. Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin. Clin Exp Immunol 2009; 157: 60-70.
34. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, Koezuka Y et al. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999; 163: 4647-4650. (Pubitemid 29501223)
35. Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alphagalactosylceramide in mice. J Immunol 2001; 166: 6578-6584. (Pubitemid 32467197)
36. Van Kaer L. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 2005; 5: 31-42. (Pubitemid 40070329)
37. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434: 520-525. (Pubitemid 40477061)
38. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7: 978-986. (Pubitemid 44263912)
39. Callahan JE, Herman A, Kappler JW, Marrack P. Stimulation of B10.BR T cells with superantigenic staphylococcal toxins. J Immunol 1990; 144: 2473-2479. (Pubitemid 20136645)
40. van den Heuvel MJ, Garg N, Van Kaer L, Haeryfar SM. NKT cell costimulation: experimental progress and therapeutic promise. Trends Mol Med 2011; 17: 65-77.
41. Bueno C, Lemke CD, Criado G, Baroja ML, Ferguson SS, Rahman AK et al. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity 2006; 25: 67-78. (Pubitemid 44066827)
42. Terabe M, Berzofsky JA. The role of NKT cells in tumor immunity. Adv Cancer Res 2008; 101: 277-348.
43. Nomizo A, Postol E, de Alencar R, Cardillo F, Mengel J. Natural killer T cells are required for the development of a superantigen-driven T helper type 2 immune response in mice. Immunology 2005; 116: 233-244. (Pubitemid 41368665)
44. Mizuno M, Masumura M, Tomi C, Chiba A, Oki S, Yamamura T et al. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J Autoimmun 2004; 23: 293-300. (Pubitemid 39574804)
45. Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosinetruncated analog of alpha-galactosylceramide. Arthritis Rheum 2004; 50: 305-313. (Pubitemid 38084316)
46. Miellot-Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier MC, Bessis N. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment. Immunology 2010; 130: 296-306.
47. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413: 531-534. (Pubitemid 32938752)
48. Haeryfar SM, Lan Z, Leon-Ponte M, Duffy KR, Ge W, Liu Wet al. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH. Transplantation 2008; 86: 460-468.
49. Forestier C, Takaki T, Molano A, Im JS, Baine I, Jerud ES et al. Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J Immunol 2007; 178: 1415-1425. (Pubitemid 46154612)
50. Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 2008; 180: 5167-5171.
51. Rahman AK, Bonsor DA, Herfst CA, Pollard F, Peirce M, Wyatt AW et al. The T cell receptor beta-chain second complementarity determining region loop (CDR2beta) governs T cell activation and Vbeta specificity by bacterial superantigens. J Biol Chem 2011; 286: 4871-4881.
52. Thomas D, Dauwalder O, Brun V, Badiou C, Ferry T, Etienne J et al. Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns. Infect Immun 2009; 77: 2043-2050.
53. Seo KS, Park JY, Terman DS, Bohach GA. A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staphylococcal superantigens. J Transl Med 2010; 8: 2.
54. Niedergang F, Hemar A, Hewitt CR, Owen MJ, Dautry-Varsat A, Alcover A. The Staphylococcus aureus enterotoxin B superantigen induces specific T cell receptor down-regulation by increasing its internalization. J Biol Chem 1995; 270: 12839-12845.
55. Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002; 8: 3702-3709. (Pubitemid 35424759)
56. Rhee RJ, Carlton S, Lomas JL, Lane C, Brossay L, Cioffi WG et al. Inhibition of CD1d activation suppresses septic mortality: a role for NK-T cells in septic immune dysfunction. J Surg Res 2003; 115: 74-81. (Pubitemid 37323951)
57. Berzofsky JA, Terabe M. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J Immunol 2008; 180: 3627-3635.
58. Arrenberg P, Halder R, Kumar V. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J Cell Physiol 2009; 218: 246-250.
59. Ragin MJ, Sahu N, August A. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure. Infect Immun 2006; 74: 282-288. (Pubitemid 43023083)
60. Ito K, Bian HJ, Molina M, Han J, Magram J, Saar E et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 1996; 183: 2635-2644. (Pubitemid 26192372)
61. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623-1626. (Pubitemid 27516281)
62. Gui M, Li J, Wen LJ, Hardy RR, Hayakawa K. TCR beta chain influences but does not solely control autoreactivity of V alpha 14J281T cells. J Immunol 2001; 167: 6239-6246. (Pubitemid 33081553)
63. Leder L, Llera A, Lavoie PM, Lebedeva MI, Li H, Sekaly RP et al. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med 1998; 187: 823-833. (Pubitemid 28141656)
64. Kasper KJ, Xi W, Rahman AK, Nooh MM, Kotb M, Sundberg EJ et al. Molecular requirements for MHC class II alpha-chain engagement and allelic discrimination by the bacterial superantigen streptococcal pyrogenic exotoxin C. J Immunol 2008; 181: 3384-3392.